Every SEC Form 3/4/5 on record for this filer (CIK 1319446) — 10 issuers, 47 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | Director | 2020-02-12 → 2026-06-23 | 10 | — |
| PBLS | Parabilis Medicines, Inc. | Director | 2026-06-09 → 2026-06-15 | 3 | — |
| RLAY | Relay Therapeutics, Inc. | Director | 2020-07-15 → 2026-06-10 | 11 | — |
| BPMC | Blueprint Medicines Corp | Director | 2015-12-02 → 2025-07-21 | 18 | −$2M |
| TNGX | Tango Therapeutics, Inc. | Director | 2021-08-12 → 2025-06-09 | 5 | — |
| EQRX | EQRx, Inc. | Executive Chairman · Director · lapsed | 2021-12-20 → 2023-11-09 | 4 | — |
| OPK | OPKO HEALTH, INC. | Director · lapsed | 2022-05-11 → 2023-06-23 | 5 | — |
| MGTA | Magenta Therapeutics, Inc. | Director · lapsed | 2018-06-20 → 2021-09-23 | 6 | — |
| FMI | Foundation Medicine, Inc. | Director · lapsed | 2016-06-20 → 2018-08-02 | 3 | — |
| EDIT | Editas Medicine, Inc. | Director · lapsed | 2016-02-02 → 2017-06-19 | 3 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
5 of 10 issuers are covered and open a security page; the rest are on file here only.
